Seiichi Yano

702 total citations
26 papers, 544 citations indexed

About

Seiichi Yano is a scholar working on Oncology, Surgery and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Seiichi Yano has authored 26 papers receiving a total of 544 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 6 papers in Surgery and 5 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Seiichi Yano's work include Cancer Immunotherapy and Biomarkers (4 papers), Adrenal Hormones and Disorders (4 papers) and CAR-T cell therapy research (3 papers). Seiichi Yano is often cited by papers focused on Cancer Immunotherapy and Biomarkers (4 papers), Adrenal Hormones and Disorders (4 papers) and CAR-T cell therapy research (3 papers). Seiichi Yano collaborates with scholars based in Japan and United States. Seiichi Yano's co-authors include Motonori Yamaguchi, Alan E. Wakeling, Steven D. Averbuch, P.F. Wadsworth, Graham H.P. Richmond, Michael G. Hutchison, Kaoru Kondo, Yoshihiro Ogawa, Kazuki Nakao and Ryuichi Sakamoto and has published in prestigious journals such as Nature Communications, Journal of Power Sources and Endocrinology.

In The Last Decade

Seiichi Yano

25 papers receiving 526 citations

Peers

Seiichi Yano
Wenyu Li China
Jason Whitt United States
Jaspreet Singh Grewal United States
Hiral Patel United States
Zakir Siddiquee United States
Wenyu Li China
Seiichi Yano
Citations per year, relative to Seiichi Yano Seiichi Yano (= 1×) peers Wenyu Li

Countries citing papers authored by Seiichi Yano

Since Specialization
Citations

This map shows the geographic impact of Seiichi Yano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Seiichi Yano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Seiichi Yano more than expected).

Fields of papers citing papers by Seiichi Yano

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Seiichi Yano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Seiichi Yano. The network helps show where Seiichi Yano may publish in the future.

Co-authorship network of co-authors of Seiichi Yano

This figure shows the co-authorship network connecting the top 25 collaborators of Seiichi Yano. A scholar is included among the top collaborators of Seiichi Yano based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Seiichi Yano. Seiichi Yano is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Miyazawa, Takashi, Naohiro Uchida, Seiichi Yano, et al.. (2023). Dectin-2 Deficiency Promotes Proinflammatory Cytokine Release From Macrophages and Impairs Insulin Secretion. Endocrinology. 165(1). 1 indexed citations
2.
Yano, Seiichi, Takashi Ishiuchi, Satoshi H. Namekawa, et al.. (2022). Histone H3K36me2 and H3K36me3 form a chromatin platform essential for DNMT3A-dependent DNA methylation in mouse oocytes. Nature Communications. 13(1). 4440–4440. 46 indexed citations
3.
Yokomoto‐Umakoshi, Maki, Hironobu Umakoshi, Seiichi Yano, et al.. (2022). Coexistence of bone and vascular disturbances in patients with endogenous glucocorticoid excess. Bone Reports. 17. 101610–101610. 8 indexed citations
4.
Yokomoto‐Umakoshi, Maki, Hironobu Umakoshi, Seiichi Yano, et al.. (2022). Coexistence of Bone and Vascular Disturbances in Patients with Endogenous Glucocorticoid Excess. SSRN Electronic Journal.
5.
Yamada, Hirotoshi, Seiichi Yano, Eisuke Magome, et al.. (2021). Concerted influence of microstructure and adsorbed water on lithium-ion conduction of Li1.3Al0.3Ti1.7(PO4)3. Journal of Power Sources. 511. 230422–230422. 11 indexed citations
6.
Yano, Seiichi, Kenji Ashida, Ryuichi Sakamoto, et al.. (2020). Human leucocyte antigen DR15, a possible predictive marker for immune checkpoint inhibitor–induced secondary adrenal insufficiency. European Journal of Cancer. 130. 198–203. 65 indexed citations
7.
Ashida, Kenji, Kenichi Kohashi, Kenji Ohe, et al.. (2019). A case of autonomous cortisol secretion in a patient with subclinical Cushing’s syndrome, GNAS mutation, and paradoxical cortisol response to dexamethasone. BMC Endocrine Disorders. 19(1). 13–13. 2 indexed citations
8.
Yano, Seiichi, Kenji Ashida, Naoko Wada, et al.. (2019). A Case of Acute Exacerbation of Chronic Adrenal Insufficiency Due to Ipilimumab Treatment for Advanced Melanoma. American Journal of Case Reports. 20. 106–110. 5 indexed citations
9.
Ashida, Kenji, Seiichi Yano, Kenji Ohe, et al.. (2019). A Case of Nivolumab-Induced Acute-Onset Type 1 Diabetes Mellitus in Melanoma. Current Oncology. 26(1). 115–118. 20 indexed citations
10.
Yano, Seiichi, Kenji Ashida, Hiromi Nagata, et al.. (2018). Nivolumab-induced thyroid dysfunction lacking antithyroid antibody is frequently evoked in Japanese patients with malignant melanoma. BMC Endocrine Disorders. 18(1). 36–36. 11 indexed citations
11.
Inoue, Hiroshi, Seiichi Yano, Nao Hasuzawa, et al.. (2018). Autoimmune-Related Primary Hypoparathyroidism Possibly Induced by the Administration of Pembrolizumab: A Case Report. Journal of Oncology Practice. 14(7). 449–451. 22 indexed citations
12.
Ijiri, Kosei, Kazutoshi Hida, Seiichi Yano, Setsuro Komiya, & Yugo Iwasaki. (2009). Traumatic spinal-cord herniation associated with pseudomeningocele after lower-thoracic nerve-root avulsion. Spinal Cord. 47(11). 829–831. 13 indexed citations
13.
Aoyama, Takahiko, Kazutoshi Hida, Seiichi Yano, et al.. (2009). Malpositioned spinal instrument as a possible cause of superficial siderosis. Spinal Cord. 47(11). 826–828. 3 indexed citations
14.
Hida, Kazutoshi, et al.. (2007). Ultra-early MRI showing no abnormality in a fall victim presenting with tetraparesis. Spinal Cord. 45(10). 695–699. 11 indexed citations
15.
Yano, Seiichi, Motonori Yamaguchi, & Rui-Ping Dong. (2003). EGFR tyrosine kinase inhibitor "gefitinib (Iressa)" for cancer therapy.. Folia Pharmacologica Japonica. 122(6). 491–497. 17 indexed citations
16.
Yano, Seiichi, et al.. (1996). Antitumor Effect of CGP41251, a New Selective Protein Kinase C Inhibitor, on Human Non-Small Cell Lung Cancer Cells. The Japanese Journal of Pharmacology. 70(1). 65–72. 29 indexed citations
17.
Yanagawa, Hiroaki, et al.. (1995). Contrasting Effect of Interleukin-13 on Interleukin-1 Receptor Antagonist and Proinflammatory Cytokine Production by Human Alveolar Macrophages. American Journal of Respiratory Cell and Molecular Biology. 12(1). 71–76. 31 indexed citations
18.
Yano, Seiichi, et al.. (1995). Anti-tumour effect of aromatase inhibitor, CGS16949A, on human breast cancer cells. European Journal of Pharmacology Molecular Pharmacology. 289(2). 217–222. 6 indexed citations
19.
Yano, Seiichi, Kazuki Nakao, Francisco Eiichi Fujita, et al.. (1995). Antitumor activity of the new selective protein kinase C inhibitor 4'-N-benzoyl staurosporine on murine and human tumor models.. PubMed. 45(11). 1225–30. 15 indexed citations
20.
Sone, S, E Orino, Kana Mizuno, et al.. (1994). Production of IL-1 and its receptor antagonist is regulated differently by IFN-gamma and IL-4 in human monocytes and alveolar macrophages. European Respiratory Journal. 7(4). 657–663. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026